Ono Pharmaceutical Co., Ltd. (4528.T) is in Healthcare, Drug Manufacturers - General, based in Japan, listed on Tokyo. Market cap 1.06T JPY. 52-week range 1,760.00 to 2,674.50 JPY. Trailing P/E 13.9. Data as of 2026-10-09.
Ono Pharmaceutical Co., Ltd. produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo intravenous infusion and Kyprolis intravenous injection for malignant tumors; Emend capsule intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; Mektovi, Velexbru, and Braftovi capsules for malignant tumors; and ADLUMIZ tablets for cancer cachexia. The company also provides Glactiv ...